Connect with us

Hi, what are you looking for?


Gov’t eyes 80M coronavirus vaccine doses

By Vann Marlo M. Villegas and Charmaine A. Tadalan, Reporters

THE PHILIPPINE government expects millions of coronavirus vaccine doses to arrive next year as it continues negotiations with drug companies for supply.

The state is in talks with British drugmaker AstraZeneca Plc for 20 million doses that will be allotted to the government, and 10 million more for the private sector, vaccine czar Carlito G. Galvez, Jr. said at a televised Cabinet meeting on Saturday

“For the Western-based vaccines, the earliest is May,” he said.

The government is also signing a contract with Serum Institute of India Ptv. Ltd. by January, which had committed 30 million doses for the Philippines, Mr. Galvez said.

He also said they were in talks with US drug company Pfizer, Inc., while Moderna, Inc. has agreed to ship 20 million doses. Pfizer and Moderna are frontrunners in vaccine development, both reporting more than 90% efficacy rate.

“If we will get Novavax, Astrazeneca, Pfizer, Johnson & Johnson and also Moderna, we might have more or less 80 million doses,” Mr. Galvez said.

Moderna, Inc. has agreed to fast-track the shipment of coronavirus vaccines to the Philippines, Foreign Affairs Secretary Teodoro L. Locsin, Jr. said on Sunday.

“Moderna on board and accelerating huge shipment,” he tweeted, citing Philippine Ambassador to the United States Jose Manuel G. Romualdez. “Everything’s falling back into place.”

“We will have a complete range of vaccines from least effective to most available for everyone to choose from,” he added.

Mr. Locsin last week said a government official had “dropped the ball” in negotiations to get 10 million doses of COVID-19 vaccines from Pfizer, Inc.

Mr. Romualdez later said the Philippine government could secure as many as 25 million doses from Moderna and Arcturus Therapeutics Holdings, Inc.

This comes ahead of a plan to convene the Senate committee of the whole on Jan. 11 to inquire into the state’s COVID-19 vaccination program.

Mr. Galvez said they negotiated with Russia’s Gamaleya Research Institute of Epidemiology and Microbiology last week for 25 million doses, hoping that they close a deal by January and have these produced by February.

He also said that they were negotiating with Chinese drugmaker Sinovac Biotech Ltd., disputing claims that they were prioritizing the Chinese company.

“It is a portfolio. Our first contract will be with AstraZeneca,” Mr. Galvez said in mixed English and Filipino. Next is Covovax vaccine from Novavax, Inc. and Serum Institute of India Ptv. Ltd., then Pfizer and Johnson & Johnson, he added.

Moderna, Gamaleya and Sinovac might follow suit.

The government is aiming to vaccinate 20 million people yearly in the next three years.

President Rodrigo R. Duterte has signed an executive order allowing the local Food and Drugs Administration (FDA) to issue an emergency use authorization for coronavirus drugs and vaccines.

This will cut the approval process to 21 days from six months.

Presidential spokesman Harry L. Roque on Saturday said Pfizer had applied for emergency use in the Philippines. The US has approved its vaccine for emergency use.

Meanwhile, the Department of Health (DoH) is preparing for the rollout of the vaccines for priority groups, Napoleon L. Arevalo, director of the agency’s Disease Prevention and Control Bureau, told an online news briefing last week. Vaccinations could start in April, he said.

Health workers, senior citizens and jail personnel would be prioritized, Mr. Arevalo said.

Health Secretary Francisco T. Duque III said at the same briefing the poor would also be prioritized as ordered by President Rodrito R. Duterte.

He said health authorities would monitor potential adverse effects after inoculation.

“We really just have to monitor these as closely as we can  and most importantly, make sure that the surveillance is adequate to be able to identify people who might be developing acute or latent side effects,” Mr. Duque said.

Congress has set aside P2.5 billion under the Department of Health budget for 2021 for the immunization program and P70 billion more in unprogrammed funds for procurement, distribution and storage.

There is also a P10-billion standby fund, bringing the total vaccine allocation to P82.5 billion.

Meanwhile, Senator Francis N. Pangilinan urged the government to take decisive actions in preventing a new coronavirus strain from entering Philippine borders.

“It’s time authorities take swift action because all it takes for the new variant to spread is one person getting on a plane and landing at the Ninoy Aquino International Airport (NAIA),” he said in a statement.

He also asked the Department of Health (DoH) and an inter-agency task force (IATF) to keep the public informed to avoid causing fear or panic and monitor developments constantly.

DoH reported 883 coronavirus infections on Sunday, bringing the total to 469,886.

The death toll rose to 9,109 after 42 more patients died, while recoveries increased by 7,635 to 438,678, it said in a bulletin.

There were 22,099 active cases, 80.2% of which were mild, 9.9% did not show symptoms, 6.2% were critical, 3.2% were severe and 0.43% were moderate.

Rizal reported the highest number of new cases at 66, followed by Quezon City at 50, Benguet at 47, Davao City at 42 and Manila at 35.

DoH said two duplicates had been removed from the tally, while 10 recovered cases were reclassified as deaths. Fifteen laboratories failed to submit their data on Dec. 26, it said.

Mr. Duterte on Saturday said he would cancel face-to-face pilot classes in January after a coronavirus strain caused cases to soar in the United Kingdom.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



THE BANGKO SENTRAL ng Pilipinas (BSP) sees the country posting a wider balance of payments (BoP) deficit this year as the global outlook remains...


HMRC’s new penalty regime for late filing and late payments of VAT will be fairer but more complex with interest being charged on all...


Economic managers said they “strongly support” the creation of the Maharlika Wealth Fund (MWF), after lawmakers agreed to remove a provision in the bill...


If you’ve been waiting ages for an online order to arrive, you’re not alone. Companies including ASOS, H&M and JD Sports have been getting...


Ulster University economists expect the Northern Ireland economy to shrink next year, followed by a weak recovery in 2024. The Ulster University Economic Policy...


The number of people working in programming and computer consultancy has risen by more than 250,000 workers over the past decade, according to Census...

You May Also Like


The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Browsing history makes referring to sites and pages you’ve visited in the past seamless. It’ll help you recall what page you checked out on...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.